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Hypoxia is a common feature in solid tumors that has
been implicated in immune-evasion. Previous studies
from our group have shown that hypoxia up-regulates
the co-stimulatory receptor CD137 on activated T lym-
phocytes and on vascular endothelial cells. In this study,
we show that exposure of mouse and human tumor cell
lines to hypoxic conditions (1% O2) promotes CD137
transcription. However, the resulting mRNA is predomi-
nantly an alternatively spliced form that encodes for a
soluble variant, lacking the transmembrane domain.
Accordingly, soluble CD137 (sCD137) is detectable by
ELISA in the supernatant of hypoxia-exposed cell lines
and in the serum of tumor-bearing mice. sCD137, as
secreted by tumor cells, is able to bind to CD137-Ligand
(CD137L). Our studies on primed T lymphocytes in co-
culture with stable transfectants for CD137L demon-
strate that tumor-secreted sCD137 prevents co-stimula-
tion of T lymphocytes. Such an effect results from
preventing the interaction of CD137L with the trans-
membrane forms of CD137 expressed on T lymphocytes
undergoing activation. This mechanism is interpreted as
a molecular strategy deployed by tumors to repress lym-
phocyte co-stimulation via CD137/CD137L.
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